Back to Search Start Over

SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate

Source :
PR Newswire. December 12, 2024
Publication Year :
2024

Abstract

SK bioscience's first mRNA vaccine candidate is expected to enter clinical trials in Australia in February 2025, with interim results expected by 2026. Joint R&D project between SK and CEPI [...]

Subjects

Subjects :
Coalition for Epidemic Preparedness Innovations
Biological products industry -- Product development
Encephalitis
Lassa fever
Messenger RNA
Clinical trials
Vaccines -- Product development

Details

Language :
English
Database :
Gale General OneFile
Journal :
PR Newswire
Publication Type :
News
Accession number :
edsgcl.819639961

Tools

Authors Abstract Subjects Details